1. IRBNMU - Репозитарій Національного медичного університету імені О.О.Богомольця

Перегляд зібрання за групою - Автори Melnychuk, I.

Перейти до: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
А Б В Г Д Е Ж З И Й К Л М Н О П Р С Т У Ф Х Ц Ч Ш Щ Ъ Ы Ь Э Ю Я І Ї Є
або ж введіть декілька перших літер:  
Результати 1 до 20 із 24  далі >
Дата випускуНазваАвтор(и)
2023Approach to lymphadenopathy: how to diagnose tuberculosis lymphadenitisTanisha; Melnychuk, I.; Sharayeva, M.
2023Atrial fibrillation in coronary artery disease patients: gut microbiota composition and echocardiography indexesMelnychuk, I.; Sharayeva, M.
2024Fecal short chain fatty acids role in atrial fibrillation paroxysm pathogenesis through coronary artery disease patientsMelnychuk, I.; Lyzogub, V.
2024Fecal short chain fatty acids role in atrial fibrillation paroxysm pathogenesis through coronary artery disease patientsMelnychuk, I.; Lyzogub, V.
2023Gut microbiota and cardiometabolic risk factors in coronary artery disease patients with atrial fibrillationMelnychuk, I.
2024Gut microbiota and plasma amino acids profile connections in patients with coronary artery disease and atrial fibrillationMelnychuk, I.
2022-12Gut microbiota composition and its metabolites changes in patients with atherosclerosis and atrial fibrillationMelnychuk, I.; Lizogub, V.
2024Gut microbiota metabolites and holter ecg monitoring in coronary artery disease patients with atrial fibrillationMelnychuk, I.
2023Gut Microbiota Metabolites As A New Therapeutic Target In Patients With Coronary Artery Disease And Atrial FibrillationMelnychuk, I.; Sharaeva, M.; Kramarova, V.; Lizogub, V.; Bogomolets, O.
2023Gut Microbiota Metabolites As A New Therapeutic Target In Patients With Coronary Artery Disease And Atrial FibrillationMelnychuk, I.; Sharaeva, M.; Kramarova, V.; Lizogub, V.
2024Gut microbiota metabolites connections with echocardiography atrial fibrillation characteristics in patients with coronary artery diseaseMelnychuk, I.
2024Gut microbiota modulation by postbiotics in patients with coronary artery disease and atrial fibrillationMelnychuk, I.
2024Holter ECG monitoring and gut microbiota composition in coronary artery disease patients with atrial fibrillationMelnychuk, I.; Sharayeva, M.; Lyzogub, V.
2024Influence of the long-term postbiotics prescription on cardiometabolic risk factors in patients with coronary artery disease and atrial fibrillationMelnychuk, I.; Kramarova, V.
2023Lipid exchange and inflammatory markers in patients with coronary artery disease and atrial fibrillationMelnychuk, I.; Sharaieva, M.; Lyzogub, V.
2023Plasma amino acids pecularities and cardiometabolic risk factors in patients with coronary artery disease and atrial fibrillationMelnychuk, I.; Sharayeva, M.; Dolynna, O.; Savchenko, O.; Kramarova, V.; Lyzogub, V.
2024Plasma amino acids spectrum and holter ecg monitoring indexes in coronary artery disease patients with atrial fibrillationMelnychuk, I.; Sharayeva, M.; Kramarova, V.; Lyzogub, V.
2023Plasma amino acids spectrum as an important part of metabolomic pattern in patients with coronary artery disease and atrial fibrillationMelnychuk, I.; Lyzogub, V.
2024Plasma and platelets amino acids in coronary artery disease and atrial fibrillation patients – are they linked?Melnychuk, I.; Sharayeva, M.
2023Platelet amino acid spectrum and gut microbiota, their links in patients with coronary artery disease and atrial fibrillationMelnychuk, I.; Sharayeva, M.; Kramarova, V.; Lyzogub, V.
Результати 1 до 20 із 24  далі >